Allarity Therapeutics Q3 EPS $(0.39) Misses $(0.21) Estimate, Sales $5.000K
Benzinga Newsdesk 5 hours ago
NewsEarningsEarnings Misses
Allarity Therapeutics (NASDAQ:ALLR) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $(0.21) by 85.71 percent. This is a 105.26 percent decrease over losses of $(0.19) per
Allarity Therapeutics (NASDAQ:ALLR) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $(0.21) by 85.71 percent. This is a 105.26 percent decrease over losses of $(0.19) per share from the same period last year. The company reported $5.000 thousand in sales this quarter.